Blood Center rezoning on Upper East Side approved

Proposed 600,000-square-foot campus will get City Council consideration

New York /
Sep.September 23, 2021 11:00 AM
Longfellow Real Estate Partners CEO Adam Sichol with renderings of 310 East 67th Street (Friends UES, Rendering by DBOX, Longfellow)

Longfellow Real Estate Partners CEO Adam Sichol with renderings of 310 East 67th Street (Friends UES, Rendering by DBOX, Longfellow)

A controversial plan to expand the New York Blood Center in the Upper East Side has advanced through the City Planning Commission.

The commission voted 8-to-2 in favor of rezoning for the Center East project. The City Council will consider the proposal for the 600,000-square-foot life science hub, according to Real Estate Weekly.

The Blood Center, located at 310 East 67th Street, is aiming to build a state-of-the-art facility that will play a major part in the city’s life science innovation. The three-story headquarters would be replaced by a 334-foot building.

New facilities would serve as offices and labs for the Blood Center, as well as for other life science firms and medical partners.

“Our vision for a state-of-the-art life science facility will not only ensure the nonprofit Blood Center continues to provide safe, affordable blood services to the region’s hospitals, but enable the center to significantly expand its life-saving research on COVID-19 and blood-related diseases in collaboration with institutions and biotechnology partners all under the same roof,” said Rob Purvis, an executive vice president with the Blood Center.

The hub is being developed with Longfellow Real Estate Partners.

The project is facing some fierce pushback, including City Council member Ben Kallos and the community around the Blood Center.

A major point of contention has been the size of the building, which prompted the rezoning proposal through the ULURP process. The maximum height of buildings in the area is 75 feet high, meaning the proposed tower would more than quadruple that mark. The proposed height sparked complaints the building could cast shadows over a nearby school and park.

Another point of criticism focused on the perceived lack of transparency surrounding the facility’s potential work. The lab is expected to process microbes “indigenous or exotic, and they can cause serious or potentially lethal disease through respiratory transmission,” according to the CDC.

[REW] — Holden Walter-Warner





    Related Articles

    arrow_forward_ios
    Elle International's Constance Benqué (Getty Images, iStock)
    Elle, luxury brands enter hotel market
    Elle, luxury brands enter hotel market
    “The New Kings of New York” rockets to top of Amazon charts
    “The New Kings of New York” rockets to top of Amazon charts
    “The New Kings of New York” rockets to top of Amazon charts
    REBNY president James Whelan (REBNY, iStock/Photo Illustration by Steven Dilakian for The Real Deal)
    Construction pipeline soars 69%: REBNY
    Construction pipeline soars 69%: REBNY
    3 New York Avenue in Jersey City, NJ (Google Maps, iStock)
    Developers land $97M for Jersey City multifamily
    Developers land $97M for Jersey City multifamily
    Gopuff co-CEO Rafael Ilishayev (Gopuff, iStock)
    Gopuff scaling back warehouse footprint amid rapid-delivery slowdown
    Gopuff scaling back warehouse footprint amid rapid-delivery slowdown
    Incoming WeWork CFO Andre Fernandez (WeWork, iStock)
    WeWork names new CFO
    WeWork names new CFO
    Brian R. Steinwurtzel and 100 Pearl Street (GFP Real Estate, LoopNet, iStock/Photo Illustration by Steven Dilakian for The Real Deal)
    Squash club starting a racket at 100 Pearl Street office tower
    Squash club starting a racket at 100 Pearl Street office tower
    Upflex co-founders Christophe Garnier and Ginger Dhaliwal (Upflex, LinkedIn/Ginger Dhaliwal, iStock)
    Upflex raises $30M, signaling rise of flex-office aggregators
    Upflex raises $30M, signaling rise of flex-office aggregators
    arrow_forward_ios

    The Deal's newsletters give you the latest scoops, fresh headlines, marketing data, and things to know within the industry.

    Loading...